Does multiparametric MRI increase Oncologic outcomes in prostate cancer?

Loading...
Thumbnail Image
Identifiers

Publication date

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

The purpose of this study is to compare the 4-year biochemical disease-free survival (BDFS) of patients with prostate cancer (PCa) staged according to multiparametric MRI (mpMRI) and treated with radical prostatectomy (RP) versus intensity-modulated radiation therapy (IMRT) ≥76 Gy ± hormonal therapy (HT).

Description

Keywords

Bibliographic reference

Couñago, F., del Cerro, E., Díaz Gavela, A., Rodríguez Luna, J. M., Marcos, F. J., Pérez-Coca, J., Thuissard, I. J., Olaciregui, K., Mateo, M., & Sanz-Rosa, D. (2015). Does multiparametric MRI increase Oncologic outcomes in prostate cancer? In: XVIII Congreso de la SEOR. Clinical & Translational Oncology, 17(extra. 1), 103.

Type of document